Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
The global market for Competent Cells was estimated to be worth US$ 1989 million in 2023 and is forecast to a readjusted size of US$ 3782 million by 2030 with a CAGR of 9.5% during the forecast period 2024-2030.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Competent Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Competent Cells.
The Competent Cells market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Competent Cells market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Competent Cells companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
麻豆原创 Segmentation
By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
Segment by Type
Chemically Competent Cells
Electrocompetent Cells
Segment by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid Creation
Cre-Lox Recombination (PIR1/PIR2)
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Competent Cells in global and regional level.
Chapter 3: Detailed analysis of Competent Cells company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Competent Cells revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Competent Cells Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Competent Cells 麻豆原创 Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Chemically Competent Cells
1.2.3 Electrocompetent Cells
1.3 麻豆原创 by Application
1.3.1 Global Competent Cells 麻豆原创 Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable DNA Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded DNA Production
1.3.9 Bacmid Creation
1.3.10 Cre-Lox Recombination (PIR1/PIR2)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Competent Cells 麻豆原创 Size Estimates and Forecasts
2.2 Competent Cells 麻豆原创 Size by Region: 2023 Versus 2030
2.2.1 Global Competent Cells Revenue by Region: 2019-2024
2.2.2 Global Competent Cells Revenue Forecast by Region (2025-2030)
2.2.3 Global Competent Cells Revenue 麻豆原创 Share by Region (2019-2030)
3 Global Competent Cells by Company
3.1 Global Competent Cells Revenue by Company (2019-2024)
3.2 Global Competent Cells Revenue Share by Company (2019-2024)
3.3 Competitive Landscape
3.3.1 Key Competent Cells Companies around the World: Ranking by Revenue
3.3.2 Global Competent Cells 麻豆原创 Concentration Ratio (CR5 and HHI) & (2019-2024)
3.3.3 Global Competent Cells 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Competent Cells Companies Headquarters & Product Type
3.4.1 Competent Cells Companies Headquarters
3.4.2 Global Competent Cells Companies Product & Service
3.4.3 Date of International Companies Enter into Competent Cells 麻豆原创
3.5 Global Competent Cells Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Merck KGaA
4.1.1 Merck KGaA Company Information
4.1.2 Merck KGaA Description, Business Overview
4.1.3 Merck KGaA Competent Cells Products Offered
4.1.4 Merck KGaA Competent Cells Revenue and Gross Margin (2019-2024)
4.1.5 Merck KGaA Competent Cells Revenue by Product in 2023
4.1.6 Merck KGaA Competent Cells Revenue by Application in 2023
4.1.7 Merck KGaA Competent Cells Revenue by Geographic Area in 2023
4.1.8 Merck KGaA Recent Developments
4.2 Thermo Fisher Scientific
4.2.1 Thermo Fisher Scientific Company Information
4.2.2 Thermo Fisher Scientific Description, Business Overview
4.2.3 Thermo Fisher Scientific Competent Cells Products Offered
4.2.4 Thermo Fisher Scientific Competent Cells Revenue and Gross Margin (2019-2024)
4.2.5 Thermo Fisher Scientific Competent Cells Revenue by Product in 2023
4.2.6 Thermo Fisher Scientific Competent Cells Revenue by Application in 2023
4.2.7 Thermo Fisher Scientific Competent Cells Revenue by Geographic Area in 2023
4.2.8 Thermo Fisher Scientific Recent Developments
4.3 Agilent Technologies
4.3.1 Agilent Technologies Company Information
4.3.2 Agilent Technologies Description, Business Overview
4.3.3 Agilent Technologies Competent Cells Products Offered
4.3.4 Agilent Technologies Competent Cells Revenue and Gross Margin (2019-2024)
4.3.5 Agilent Technologies Competent Cells Revenue by Product in 2023
4.3.6 Agilent Technologies Competent Cells Revenue by Application in 2023
4.3.7 Agilent Technologies Competent Cells Revenue by Geographic Area in 2023
4.3.8 Agilent Technologies Recent Developments
4.4 Takara Bio
4.4.1 Takara Bio Company Information
4.4.2 Takara Bio Description, Business Overview
4.4.3 Takara Bio Competent Cells Products Offered
4.4.4 Takara Bio Competent Cells Revenue and Gross Margin (2019-2024)
4.4.5 Takara Bio Competent Cells Revenue by Product in 2023
4.4.6 Takara Bio Competent Cells Revenue by Application in 2023
4.4.7 Takara Bio Competent Cells Revenue by Geographic Area in 2023
4.4.8 Takara Bio Recent Developments
4.5 Promega Corporation
4.5.1 Promega Corporation Company Information
4.5.2 Promega Corporation Description, Business Overview
4.5.3 Promega Corporation Competent Cells Products Offered
4.5.4 Promega Corporation Competent Cells Revenue and Gross Margin (2019-2024)
4.5.5 Promega Corporation Competent Cells Revenue by Product in 2023
4.5.6 Promega Corporation Competent Cells Revenue by Application in 2023
4.5.7 Promega Corporation Competent Cells Revenue by Geographic Area in 2023
4.5.8 Promega Corporation Recent Developments
4.6 Beijing TransGen Biotech
4.6.1 Beijing TransGen Biotech Company Information
4.6.2 Beijing TransGen Biotech Description, Business Overview
4.6.3 Beijing TransGen Biotech Competent Cells Products Offered
4.6.4 Beijing TransGen Biotech Competent Cells Revenue and Gross Margin (2019-2024)
4.6.5 Beijing TransGen Biotech Competent Cells Revenue by Product in 2023
4.6.6 Beijing TransGen Biotech Competent Cells Revenue by Application in 2023
4.6.7 Beijing TransGen Biotech Competent Cells Revenue by Geographic Area in 2023
4.6.8 Beijing TransGen Biotech Recent Development
4.7 GeneScript Corporation
4.7.1 GeneScript Corporation Company Information
4.7.2 GeneScript Corporation Description, Business Overview
4.7.3 GeneScript Corporation Competent Cells Products Offered
4.7.4 GeneScript Corporation Competent Cells Revenue and Gross Margin (2019-2024)
4.7.5 GeneScript Corporation Competent Cells Revenue by Product in 2023
4.7.6 GeneScript Corporation Competent Cells Revenue by Application in 2023
4.7.7 GeneScript Corporation Competent Cells Revenue by Geographic Area in 2023
4.7.8 GeneScript Corporation Recent Development
4.8 Yeastern Biotech
4.8.1 Yeastern Biotech Company Information
4.8.2 Yeastern Biotech Description, Business Overview
4.8.3 Yeastern Biotech Competent Cells Products Offered
4.8.4 Yeastern Biotech Competent Cells Revenue and Gross Margin (2019-2024)
4.8.5 Yeastern Biotech Competent Cells Revenue by Product in 2023
4.8.6 Yeastern Biotech Competent Cells Revenue by Application in 2023
4.8.7 Yeastern Biotech Competent Cells Revenue by Geographic Area in 2023
4.8.8 Yeastern Biotech Recent Development
4.9 New England Biolabs
4.9.1 New England Biolabs Company Information
4.9.2 New England Biolabs Description, Business Overview
4.9.3 New England Biolabs Competent Cells Products Offered
4.9.4 New England Biolabs Competent Cells Revenue and Gross Margin (2019-2024)
4.9.5 New England Biolabs Competent Cells Revenue by Product in 2023
4.9.6 New England Biolabs Competent Cells Revenue by Application in 2023
4.9.7 New England Biolabs Competent Cells Revenue by Geographic Area in 2023
4.9.8 New England Biolabs Recent Development
4.10 QIAGEN N.V.
4.10.1 QIAGEN N.V. Company Information
4.10.2 QIAGEN N.V. Description, Business Overview
4.10.3 QIAGEN N.V. Competent Cells Products Offered
4.10.4 QIAGEN N.V. Competent Cells Revenue and Gross Margin (2019-2024)
4.10.5 QIAGEN N.V. Competent Cells Revenue by Product in 2023
4.10.6 QIAGEN N.V. Competent Cells Revenue by Application in 2023
4.10.7 QIAGEN N.V. Competent Cells Revenue by Geographic Area in 2023
4.10.8 QIAGEN N.V. Recent Development
4.11 OriGene Technologies
4.11.1 OriGene Technologies Company Information
4.11.2 OriGene Technologies Description, Business Overview
4.11.3 OriGene Technologies Competent Cells Products Offered
4.11.4 OriGene Technologies Competent Cells Revenue and Gross Margin (2019-2024)
4.11.5 OriGene Technologies Competent Cells Revenue by Product in 2023
4.11.6 OriGene Technologies Competent Cells Revenue by Application in 2023
4.11.7 OriGene Technologies Competent Cells Revenue by Geographic Area in 2023
4.11.8 OriGene Technologies Recent Development
4.12 Lucigen
4.12.1 Lucigen Company Information
4.12.2 Lucigen Description, Business Overview
4.12.3 Lucigen Competent Cells Products Offered
4.12.4 Lucigen Competent Cells Revenue and Gross Margin (2019-2024)
4.12.5 Lucigen Competent Cells Revenue by Product in 2023
4.12.6 Lucigen Competent Cells Revenue by Application in 2023
4.12.7 Lucigen Competent Cells Revenue by Geographic Area in 2023
4.12.8 Lucigen Recent Development
4.13 Zymo Research
4.13.1 Zymo Research Company Information
4.13.2 Zymo Research Description, Business Overview
4.13.3 Zymo Research Competent Cells Products Offered
4.13.4 Zymo Research Competent Cells Revenue and Gross Margin (2019-2024)
4.13.5 Zymo Research Competent Cells Revenue by Product in 2023
4.13.6 Zymo Research Competent Cells Revenue by Application in 2023
4.13.7 Zymo Research Competent Cells Revenue by Geographic Area in 2023
4.13.8 Zymo Research Recent Development
4.14 Bio-Rad Laboratories
4.14.1 Bio-Rad Laboratories Company Information
4.14.2 Bio-Rad Laboratories Description, Business Overview
4.14.3 Bio-Rad Laboratories Competent Cells Products Offered
4.14.4 Bio-Rad Laboratories Competent Cells Revenue and Gross Margin (2019-2024)
4.14.5 Bio-Rad Laboratories Competent Cells Revenue by Product in 2023
4.14.6 Bio-Rad Laboratories Competent Cells Revenue by Application in 2023
4.14.7 Bio-Rad Laboratories Competent Cells Revenue by Geographic Area in 2023
4.14.8 Bio-Rad Laboratories Recent Development
4.15 Bioline
4.15.1 Bioline Company Information
4.15.2 Bioline Description, Business Overview
4.15.3 Bioline Competent Cells Products Offered
4.15.4 Bioline Competent Cells Revenue and Gross Margin (2019-2024)
4.15.5 Bioline Competent Cells Revenue by Product in 2023
4.15.6 Bioline Competent Cells Revenue by Application in 2023
4.15.7 Bioline Competent Cells Revenue by Geographic Area in 2023
4.15.8 Bioline Recent Development
4.16 Delphi Genetics
4.16.1 Delphi Genetics Company Information
4.16.2 Delphi Genetics Description, Business Overview
4.16.3 Delphi Genetics Competent Cells Products Offered
4.16.4 Delphi Genetics Competent Cells Revenue and Gross Margin (2019-2024)
4.16.5 Delphi Genetics Competent Cells Revenue by Product in 2023
4.16.6 Delphi Genetics Competent Cells Revenue by Application in 2023
4.16.7 Delphi Genetics Competent Cells Revenue by Geographic Area in 2023
4.16.8 Delphi Genetics Recent Development
4.17 IBA GmBH
4.17.1 IBA GmBH Company Information
4.17.2 IBA GmBH Description, Business Overview
4.17.3 IBA GmBH Competent Cells Products Offered
4.17.4 IBA GmBH Competent Cells Revenue and Gross Margin (2019-2024)
4.17.5 IBA GmBH Competent Cells Revenue by Product in 2023
4.17.6 IBA GmBH Competent Cells Revenue by Application in 2023
4.17.7 IBA GmBH Competent Cells Revenue by Geographic Area in 2023
4.17.8 IBA GmBH Recent Development
4.18 Cell Applications
4.18.1 Cell Applications Company Information
4.18.2 Cell Applications Description, Business Overview
4.18.3 Cell Applications Competent Cells Products Offered
4.18.4 Cell Applications Competent Cells Revenue and Gross Margin (2019-2024)
4.18.5 Cell Applications Competent Cells Revenue by Product in 2023
4.18.6 Cell Applications Competent Cells Revenue by Application in 2023
4.18.7 Cell Applications Competent Cells Revenue by Geographic Area in 2023
4.18.8 Cell Applications Recent Development
4.19 BioDynamics Laboratory
4.19.1 BioDynamics Laboratory Company Information
4.19.2 BioDynamics Laboratory Description, Business Overview
4.19.3 BioDynamics Laboratory Competent Cells Products Offered
4.19.4 BioDynamics Laboratory Competent Cells Revenue and Gross Margin (2019-2024)
4.19.5 BioDynamics Laboratory Competent Cells Revenue by Product in 2023
4.19.6 BioDynamics Laboratory Competent Cells Revenue by Application in 2023
4.19.7 BioDynamics Laboratory Competent Cells Revenue by Geographic Area in 2023
4.19.8 BioDynamics Laboratory Recent Development
4.20 Scarab Genomics
4.20.1 Scarab Genomics Company Information
4.20.2 Scarab Genomics Description, Business Overview
4.20.3 Scarab Genomics Competent Cells Products Offered
4.20.4 Scarab Genomics Competent Cells Revenue and Gross Margin (2019-2024)
4.20.5 Scarab Genomics Competent Cells Revenue by Product in 2023
4.20.6 Scarab Genomics Competent Cells Revenue by Application in 2023
4.20.7 Scarab Genomics Competent Cells Revenue by Geographic Area in 2023
4.20.8 Scarab Genomics Recent Development
4.21 GCC Biotech
4.21.1 GCC Biotech Company Information
4.21.2 GCC Biotech Description, Business Overview
4.21.3 GCC Biotech Competent Cells Products Offered
4.21.4 GCC Biotech Competent Cells Revenue and Gross Margin (2019-2024)
4.21.5 GCC Biotech Competent Cells Revenue by Product in 2023
4.21.6 GCC Biotech Competent Cells Revenue by Application in 2023
4.21.7 GCC Biotech Competent Cells Revenue by Geographic Area in 2023
4.21.8 GCC Biotech Recent Development
4.22 SMOBIO Technology
4.22.1 SMOBIO Technology Company Information
4.22.2 SMOBIO Technology Description, Business Overview
4.22.3 SMOBIO Technology Competent Cells Products Offered
4.22.4 SMOBIO Technology Competent Cells Revenue and Gross Margin (2019-2024)
4.22.5 SMOBIO Technology Competent Cells Revenue by Product in 2023
4.22.6 SMOBIO Technology Competent Cells Revenue by Application in 2023
4.22.7 SMOBIO Technology Competent Cells Revenue by Geographic Area in 2023
4.22.8 SMOBIO Technology Recent Development
4.23 Edge BioSystems
4.23.1 Edge BioSystems Company Information
4.23.2 Edge BioSystems Description, Business Overview
4.23.3 Edge BioSystems Competent Cells Products Offered
4.23.4 Edge BioSystems Competent Cells Revenue and Gross Margin (2019-2024)
4.23.5 Edge BioSystems Competent Cells Revenue by Product in 2023
4.23.6 Edge BioSystems Competent Cells Revenue by Application in 2023
4.23.7 Edge BioSystems Competent Cells Revenue by Geographic Area in 2023
4.23.8 Edge BioSystems Recent Development
5 Breakdown Data by Type
5.1 Global Competent Cells Revenue by Type (2019-2024)
5.2 Global Competent Cells Revenue Forecast by Type (2025-2030)
5.3 Competent Cells Revenue 麻豆原创 Share by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Competent Cells Revenue by Application (2019-2024)
6.2 Global Competent Cells Revenue Forecast by Application (2025-2030)
6.3 Competent Cells Revenue 麻豆原创 Share by Application (2019-2030)
7 North America
7.1 North America Competent Cells 麻豆原创 Size YoY Growth 2019-2030
7.2 North America Competent Cells 麻豆原创 Facts & Figures by Country (2019-2030)
7.3 North America Competent Cells Revenue by Type (2019-2024)
7.4 North America Competent Cells Revenue by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Competent Cells 麻豆原创 Size YoY Growth 2019-2030
8.2 Asia-Pacific Competent Cells 麻豆原创 Facts & Figures by Region (2019-2030)
8.3 Asia-Pacific Competent Cells Revenue by Type (2019-2024)
8.4 Asia-Pacific Competent Cells Revenue by Application (2019-2024)
9 Europe
9.1 Europe Competent Cells 麻豆原创 Size YoY Growth 2019-2030
9.2 Europe Competent Cells 麻豆原创 Facts & Figures by Country (2019-2030)
9.3 Europe Competent Cells Revenue by Type (2019-2024)
9.4 Europe Competent Cells Revenue by Application (2019-2024)
10 Latin America
10.1 Latin America Competent Cells 麻豆原创 Size YoY Growth 2019-2030
10.2 Latin America Competent Cells 麻豆原创 Facts & Figures by Country (2019-2030)
10.3 Latin America Competent Cells Revenue by Type (2019-2024)
10.4 Latin America Competent Cells Revenue by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Competent Cells 麻豆原创 Size YoY Growth 2019-2030
11.2 Middle East and Africa Competent Cells 麻豆原创 Facts & Figures by Country (2019-2030)
11.3 Middle East and Africa Competent Cells Revenue by Type (2019-2024)
11.4 Middle East and Africa Competent Cells Revenue by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Competent Cells Supply Chain Analysis
12.2 Competent Cells Key Raw Materials and Upstream Suppliers
12.3 Competent Cells Clients Analysis
12.4 Competent Cells Sales Channel and Sales Model Analysis
12.4.1 Competent Cells Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Competent Cells Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Competent Cells Distributors
13 麻豆原创 Dynamics
13.1 Competent Cells Industry Trends
13.2 Competent Cells 麻豆原创 Drivers
13.3 Competent Cells 麻豆原创 Challenges
13.4 Competent Cells 麻豆原创 Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
听
听
*If Applicable.
